What is AMS Micromedical?
AMS Micromedical operates as a premier manufacturer at the intersection of engineering and healthcare, specializing in high-precision micro machining, CNC Swiss machining, and advanced injection molded components. The company serves as a vital link in the medical supply chain, providing comprehensive services that range from initial engineering design to final parts finishing and laser engraving. Operating out of a 29,000 square foot ISO-certified and FDA-approved facility, the firm is uniquely positioned to deliver ultra-precise medical solutions that meet the stringent quality standards required by global healthcare providers. Their market position is defined by a synthesis of technical expertise and rigorous regulatory compliance, making them a preferred partner for OEMs seeking reliable, innovative micro-device production.
How much funding has AMS Micromedical raised?
AMS Micromedical has raised a total of $382K across 2 funding rounds:
Debt
$150K
Debt
$232K
Debt (2020): $150K with participation from PPP
Debt (2021): $232K led by PPP
Key Investors in AMS Micromedical
PPP
Public-Private Partnership
What's next for AMS Micromedical?
With the successful acquisition of $232K, AMS Micromedical is well-positioned to accelerate its strategic roadmap, focusing on the integration of next-generation manufacturing technologies and the expansion of its facility throughput. The company is likely to prioritize investments in automated precision systems and enhanced quality control protocols to maintain its competitive edge in the micromedical sector. As the demand for miniaturized medical devices continues to rise, AMS Micromedical's focus on scaling its high-precision capabilities will be instrumental in capturing additional market share. Future growth will likely be characterized by deeper partnerships with medical device innovators and a continued emphasis on operational excellence within their FDA-approved manufacturing environment.
See full AMS Micromedical company page
